ITIC

ITIC Total Liabilities

$93.55MQuarterly · USD

Period ending:

ITIC FY Total LiabilitiesUSD
ITIC FY Total Liabilities1985-12-31: $2.10M1986-12-31: $2.30M1987-12-31: $1.70M1988-12-31: $2.10M1989-12-31: $2.20M1990-12-31: $2.30M1991-12-31: $2.70M1992-12-31: $7.40M1993-12-31: $2.00M1994-12-31: $5.60M1995-12-31: $6.01M1996-12-31: $7.65M1997-12-31: $10.16M1998-12-31: $15.27M1999-12-31: $17.65M2000-12-31: $20.15M2001-12-31: $25.95M2002-12-31: $31.97M2003-12-31: $37.28M2004-12-31: $40.68M2005-12-31: $44.17M2006-12-31: $48.24M2007-12-31: $50.37M2008-12-31: $50.00M2009-12-31: $49.17M2010-12-31: $49.56M2011-12-31: $51.45M2012-12-31: $56.79M2013-12-31: $59.70M2014-12-31: $60.48M2015-12-31: $68.74M2016-12-31: $73.80M2017-12-31: $70.99M2018-12-31: $68.63M2019-12-31: $72.53M2020-12-31: $82.50M2021-12-31: $102.40M2022-12-31: $98.75M2023-12-31: $79.01M2024-12-31: $81.80M2025-12-31: $94.84M$102.40M$0.00
1985-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

ITIC total liabilities history

Total amount the company owes to creditors. The available annual fiscal periods series contains 41 observations from Dec 31, 1985 to Dec 31, 2025.

Investors Title Total Liabilities — Annual fiscal periods (USD)
Period endingTotal Liabilities (USD)
94,838,000
81,798,000
79,006,000
98,746,000
102,401,000
82,503,000
72,531,000
68,629,000
70,992,419
73,802,168
68,744,949
60,475,504
59,698,173
56,785,525
51,446,279
49,556,551
49,168,627
50,000,300
50,366,580
48,240,715
44,174,272
40,679,481
37,283,065
31,968,962
25,947,932
20,149,358
17,654,824
15,269,147
10,164,099
7,654,351
6,014,462
5,600,000
2,000,000
7,400,000
2,700,000
2,300,000
2,200,000
2,100,000
1,700,000
2,300,000
2,100,000

Compare total liabilities

All ITIC financial metrics · ITIC stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.